France· FR:64880296
SIMBRINZA 10 mg/ml + 2 mg/ml, collyre en suspension
A medicinal product containing brinzolamide + tartrate de brimonidine, registered in France by NOVARTIS EUROPHARM (IRLANDE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- BRINZOLAMIDE + TARTRATE DE BRIMONIDINE
- Manufacturer
- NOVARTIS EUROPHARM (IRLANDE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009279296251 flacon(s) polyéthylène basse densité (PEBD) de 5 ml avec compte-gouttes polyéthylène basse densité (PEBD)EUR 7.04
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Brinzolamide + tartrate de brimonidine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenBrinzolamid/Brimonidin Medical Valley 10 mg/ml + 2 mg/ml Ögondroppar, suspensionMedical Valley Invest AB
- GermanyBrinzolamid/Brimonidin AlAliud Pharma Gmbh
- NetherlandsBriduophta 10 mg/ml + 2 mg/ml, oogdruppels, suspensieViatris Limited
- United KingdomBrinzolamide 10mg/ml / Brimonidine 2mg/ml eye dropsAspire Pharma Ltd
- CzechiaBRIDUOPHTAVIATRIS LIMITED, Dublin
- SpainBRINZOLAMIDA/BRIMONIDINA STADA 10 MG/ML + 2 MG/ML COLIRIO EN SUSPENSIONLaboratorio Stada S.L.
- NorwayBrinzolamid/Brimonidin Medical ValleyMedical Valley Invest AB
- IcelandBrinzolamide/Brimonidine STADASTADA Arzneimittel AG
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Czechia · Briduophta
- Germany · Brinzolamid/Brimonidin Al, Brinzolamid/Brimonidin Axiromed
- Denmark · Brinzolamid/Brimonidin "medical Valley", Brinzolamide/Brimonidine Stada
- Spain · Brinzolamida/Brimonidina Stada, Brinzolamida/Brimonidina Zentiva
- Finland · Brinzolamide/Brimonidine Stada
- United Kingdom (Northern Ireland) · Brinzolamide + Brimonidine Blumont Pharma, Brinzolamide/Brimonidine Tartrate Aspire Pharma
- Greece · Leznoda
- Iceland · Brinzolamide/Brimonidine Stada, Simbrinza
- Liechtenstein · Simbrinza
- Netherlands · Briduophta, Brinzolamide/Brimonidine Blumont
- Norway · Brinzolamid/Brimonidin Medical Valley, Simbrinza
- Portugal · Fixobim
- Sweden · Brinzolamid/Brimonidin Medical Valley, Brinzolamid/Brimonidin Zentiva
- Slovakia · Briduophta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4d78507a-672b-4c4a-b9ef-90e00c3dbaf5 GET /v1/drugs/4d78507a-672b-4c4a-b9ef-90e00c3dbaf5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64880296",
"date_amm": "2014-07-18",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/14/933",
"substance": "BRINZOLAMIDE + TARTRATE DE BRIMONIDINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "collyre en suspension",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about brinzolamide + tartrate de brimonidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.